Table 2.
Metric Set | Specific Metric | Conformance Across Whole Sample (%) | P |
---|---|---|---|
QOPI | Pain assessed by second office visit* | 99.13 | NS |
Plan of care for moderate or severe pain documented* | 30.58 | .036 | |
Constipation assessed at time of narcotic prescription | 90.16 | .014 | |
Patient emotional well-being assessed by second office visit | 68.04 | .001 | |
Dyspnea addressed appropriately* | 15.63 | NS | |
PEACE | Standard assessment for depression | 84.57 | NS |
Screening of symptoms during first visit | 41.09 | .001 | |
Percentage of patients screened for pain during the admission visit* | 99.13 | NS | |
For patients who screened positive for pain, the percentage with any treatment within 1 d of screening* | 2.41 | NS | |
Percentage of patients who were screened for shortness of breath during the admission visit* | 98.70 | NS | |
For patients who screened positive for dyspnea, the percent who receive treatment within 1 d of screening* | 7.05 | NS | |
For patients who screen positive for constipation, the percentage who receive treatment within 1 d of screening | 4.99 | .062 | |
For patients who screen positive for depression, the percentage who receive further assessment, counseling or medication treatment | 3.68 | NS | |
Percentage of patients with chart documentation of their preference for life-sustaining treatments | 99.78 | NS | |
Cancer-ASSIST | If a cancer patient has a cancer-related outpatient visit, then there should be screening for the presence or absence and intensity of pain using a numeric pain score* | 98.96 | NS |
If depression is diagnosed in a patient with cancer, then a treatment plan for depression should be documented | 3.68 | NS | |
If a patient with cancer is seen for an initial visit or any visit while undergoing chemotherapy at a cancer-related outpatient site, then there should be an assessment of the presence or absence of fatigue | 80.22 | .014 | |
If an outpatient with primary lung cancer or advanced cancer reports new or worsening dyspnea, then she or he should be offered symptomatic management or treatment directed at an underlying cause within 1 mo* | 10.81 | NS |
Abbreviations: ASSIST, Assessing Symptoms, Side Effects, and Indicators of Supportive Treatment; PEACE, Prepare. Embrace. Attend. Communicate. Empower.; NS, nonsignificant; QOPI, Quality Oncology Practice Initiative.
Measure concepts included in NQF-endorsed Palliative Care measures.